Bottom line The essence of microdosing semaglutide is to find the most effective, lowest dose for you, minimize side effects, and achieve lasting metabolic improvements
Additionally, it has demonstrated antioxidant activity, particularly in liver disease progression, by increasing intracellular glutathione levels and improving various liver markers
December 2, 2025: Australian Government Issues Warning About Ozempic and Reports of Suicidality, Self-Harm The Therapeutic Goods Administration in Australia (a government agency similar to the FDA in the U.S.) warns that a concerning number of patients who take Ozempic and other GLP-1s reported suicidal ideation and self-harm
In 1992, a proof-of-concept study first suggested the potential of GLP-1 as an anti-diabetes drug, as a 3-hour continuous intravenous GLP-1 infusion significantly lowered the meal-related insulin requirement in patients with diabetes
Reading the insulin syringe A U-100 insulin syringe has 100 units representing 1 mL total volume